In October 2012, Rhythmia Medical Inc was acquired by Boston Scientific Corp. Rhythmia Medical, Inc. is developing an innovative medical device for the treatment of cardiac arrhythmia. The medical device market for the treatment of cardiac arrhythmias exceeds $12 billion per annum within which Rhythmia is addressing the fastest growing segment representing one of the most attractive frontiers in medical devices. Rhythmia Medical, Inc. is developing a next generation Mapping, Visualization and Navigation system for the treatment of cardiac arrhythmias. The company recently began human clinical testing outside the US and is working with several of the leading clinicians in this field around the world. treatment.
